Hallucinations in Parkinson's disease: the clinical syndrome
Goetz, C.G.
Advances in Neurology 80: 419-423
1999
ISSN/ISBN: 0091-3952 PMID: 10410750 Document Number: 511353
Document emailed within 1 workday
Related Documents
Godwin-Austen, R.B. 1999: Psychosis and hallucinations in Parkinson's disease Advances in Neurology 80: 401-402Golden, W.E.; Lavender, R.C.; Metzer, W.S. 1989: Acute postoperative confusion and hallucinations in Parkinson disease Annals of Internal Medicine 111(3): 218-222
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Georgiev, D.; Danieli, A.; Ocepek, L.; Novak, D.; Zupancic-Kriznar, N.; Trost, M.; Pirtosek, Z. 2010: Othello syndrome in patients with Parkinson's disease Psychiatria Danubina 22(1): 94-98
Coleman, R.J. 1990: Rational management of the 'on-off' syndrome in Parkinson's disease Quarterly Journal of Medicine 74(274): 121-131
Nikitina, A.V.; Fedorova, N.V. 2013: Impulsive-compulsive syndrome in Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(7 Part 2): 32-38
Sigwald, J.; Chomette, G.; Raymondeaud, C. 1972: Antagonism and competition between Parkinson's syndrome and the chorea and athetosis syndrome. Clinical cases of the association (including an anatomoclinical case). The abnormal movements provoked by levodopa in Parkinsonian patients La semaine des hopitaux: organe fonde par l'Association d'enseignement medical des hopitaux de Paris 48(9): 609-624
Poewe, W.; Gerstenbrand, F. 1986: Clinical subtypes of Parkinson disease Wiener Medizinische Wochenschrift 136(15-16): 384-387
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Hamada, Y.; Miyamoto, K.; Inatsugi, Y.; Suzuki, H.; Kusunoki, S. 2006: A case of Parkinson's disease with neuroleptic malignant syndrome induced by paroxetine Rinsho Shinkeigaku 46(8): 575-578
Bajaj, A.; Patel, J.S. 1986: Wolff-Parkinson and White syndrome. Clinical presentation and management Central African Journal of Medicine 32(2): 43 46-9
Kappenberger, L.; Turina, M. 1985: Clinical course after surgical treatment of the Wolff-Parkinson-White syndrome Schweizerische Medizinische Wochenschrift 115(45): 1601-1603
Barbeau, A. 1972: Biochemical and clinical correlations in Parkinson's disease Revue Neurologique (Paris) 127(2): 253-264
Smolentseva, I.G.; Chupina, L.P.; Amosova, N.A.; Krivonos, O.V. 2014: Clinical evaluation of Parkinson's disease progression Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(6 Part 2): 36-40
Al-Bunyan, M.A. 2000: Parkinson`s disease. Clinical and electrophysiology evaluation Neurosciences 5(1): 46-49
Castaigne, P.; Laplane, D.; Dordain, G. 1971: Clinical experimentation with apomorphine in Parkinson's disease Research Communications in Chemical Pathology and Pharmacology 2(2): 154-158
Fischer, P.A. 1987: Long-term course in Parkinson's syndrome and cerebral polypathy (Parkinson plus) Advances in Neurology 45: 235-238
Chen, Y.-L.'; Feng, W.-J.; Zhang, X.-L. 2012: Parkinson's disease combined with overactive bladder syndrome treated with acupuncture and medication Zhongguo Zhen Jiu 32(3): 215-218